Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Jankovic

Showing results (111-120 of 670) with videos related to

Pageof 67
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|May 3, 2013
Zolpidem improves tardive dyskinesia and akathisiaOlga Waln, Joseph Jankovic
The Lancet. Neurology|April 23, 2013
Movement disorders in cerebrovascular diseaseRaja Mehanna, Joseph Jankovic
The Lancet. Neurology|July 23, 2013
Restless legs syndrome and cerebrovascular disease - authors' replyRaja Mehanna, Joseph Jankovic
Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2010
Psychogenic chorea associated with family history of Huntington diseaseRobert Fekete, Joseph Jankovic
Movement Disorders : Official Journal of the Movement Disorder Society|December 20, 2008
Hemidystonia-hemiatrophy syndromeSubhashie Wijemanne, Joseph Jankovic
CNS Drugs|July 17, 2007
Medical management of levodopa-associated motor complications in patients with Parkinson's diseaseJoseph Jankovic, Mark Stacy
Journal of the Neurological Sciences|July 5, 2024
Medication refractory restless legs syndrome: Real-world experiencePeyman Petramfar, Joseph Jankovic
Neurologic Clinics|November 30, 2014
Paroxysmal movement disordersOlga Waln, Joseph Jankovic
Drugs|February 28, 2018
Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 InhibitorsNicki Niemann, Joseph Jankovic
Drugs|March 11, 2018
Correction to: Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 InhibitorsNicki Niemann, Joseph Jankovic
Pageof 67

Showing results (111-120 of 670) with videos related to

Sort By:
Pageof 67
Movement Disorders : Official Journal of the Movement Disorder Society|May 3, 2013
Zolpidem improves tardive dyskinesia and akathisiaOlga Waln, Joseph Jankovic
The Lancet. Neurology|April 23, 2013
Movement disorders in cerebrovascular diseaseRaja Mehanna, Joseph Jankovic
The Lancet. Neurology|July 23, 2013
Restless legs syndrome and cerebrovascular disease - authors' replyRaja Mehanna, Joseph Jankovic
Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2010
Psychogenic chorea associated with family history of Huntington diseaseRobert Fekete, Joseph Jankovic
Movement Disorders : Official Journal of the Movement Disorder Society|December 20, 2008
Hemidystonia-hemiatrophy syndromeSubhashie Wijemanne, Joseph Jankovic
CNS Drugs|July 17, 2007
Medical management of levodopa-associated motor complications in patients with Parkinson's diseaseJoseph Jankovic, Mark Stacy
Journal of the Neurological Sciences|July 5, 2024
Medication refractory restless legs syndrome: Real-world experiencePeyman Petramfar, Joseph Jankovic
Neurologic Clinics|November 30, 2014
Paroxysmal movement disordersOlga Waln, Joseph Jankovic
Drugs|February 28, 2018
Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 InhibitorsNicki Niemann, Joseph Jankovic
Drugs|March 11, 2018
Correction to: Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 InhibitorsNicki Niemann, Joseph Jankovic
Pageof 67